SYMPHEOS
"SYMPHEOS" is a word mark owned by Abbott Laboratories, filed at the CIPO on April 23, 2019. It is registered and covers classes 1, 5, 9, 10, 41 and 42.
- Status
- Registered
- Since September 18, 2024
- Filed
- April 23, 2019
- Registered
- September 18, 2024
- Expires
- September 18, 2034
- Application no.
- 1958693
- Registration no.
- TMA1257202
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 6 classes
Who owns SYMPHEOS
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Abbott Laboratories
ABT · United States
Representative
Baker & McKenzie LLP
Baker & McKenzie LLP
What the mark covers
The products and services SYMPHEOS is filed for, grouped by Nice class.
Control preparations, namely, calibrating fluids for medical diagnostic instruments; control preparations, namely, calibrating fluids for laboratory instruments used for in vitro diagnostic testing and analysis.
Reagents for medical diagnosis; medical diagnostic reagents; diagnostic preparations for medical purposes namely, for medical laboratory use and for medical research; medical diagnostic test kits comprising reagents and assays for analysis and identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and pathogens.
) Research laboratory analyzers, namely, blood and biological sample chemistry analyzers and parts thereof for measuring, testing and analyzing blood, bodily fluids and tissue; Immunoassay analyzers; automated clinical molecular laboratory instruments, namely, sequencers, spectrometers, sensors and computers for scientific research purposes; laboratory sample extraction instruments; molecular diagnostic systems comprised of sequencers, spectrometers, sensors and computers, for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and pathogens; laboratory instruments for microbial screening and identification; computer software and hardware for identification and analysis of nucleic acid sequences, nucleic acids for pathogen identity, drug resistance characteristics and forensic profiles; laboratory apparatus, namely, molecular diagnostic sensors for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and pathogens; computer software for front-end processing, instrument control, data analysis and reporting for molecular diagnostic instruments; computer hardware and software for use in the field of in vitro diagnostics, namely, for remote monitoring of in vitro diagnostic instruments; electronic publications, namely, instruction sheets and manuals for in vitro diagnostic instruments, laboratory automation systems, and related software; data management software for hematology analyzers, clinical chemistry analyzers, immunoassay analyzers and blood screening instruments; computer software and hardware for remote monitoring of diagnostic instruments, namely, hematology analyzers, clinical chemistry analyzers, immunoassay analyzers and blood screening instruments; computer software and hardware for managing interface between in vitro diagnostic laboratory instruments; computer software and hardware for managing in vitro diagnostic laboratory workflow; computer software and hardware for the operation of a laboratory information management system; computer software and hardware for monitoring in vitro diagnostic instruments; computer software and hardware for monitoring laboratory diagnostic instruments; computer software and hardware for troubleshooting regarding in vitro diagnostic instruments; computer software and hardware for troubleshooting regarding laboratory diagnostic instruments; computer software for processing diagnostic medical testing data; software for use in in vitro diagnostic testing; hardware for use in in vitro diagnostic testing; laboratory instruments for in vitro diagnostic testing and analysis, namely, research and commercial laboratory analyzers for measuring, testing and analyzing blood, bodily fluids and tissue; data management and laboratory automation systems comprised of computers and computer programs for use in the field of medical diagnostics
Laboratory diagnostic instruments, namely, analyzers for in vitro diagnostic testing and analysis for medical purposes; hematology analyzers for medical diagnostic use; clinical chemistry analyzers for medical use to analyze blood and other bodily fluids and tissue; blood screening instruments for medical use
Providing online non-downloadable electronic publications, namely, instruction sheets and manuals for in vitro diagnostic instruments, laboratory automation systems, and related software
Providing technical support services regarding in vitro diagnostic laboratory instruments, laboratory automation systems, and related software and hardware, namely, troubleshooting in the nature of diagnosing problems with medical equipment; providing technical support regarding laboratory software, namely, troubleshooting of problems in relation to laboratory software in the field of in vitro diagnostics; providing remote electronic troubleshooting services in the nature of diagnosing problems with medical diagnostic instruments and software for laboratories in the field of in vitro diagnostics; providing operational monitoring services for laboratory equipment in the field of in vitro diagnostics; remote monitoring of diagnostic laboratory systems; providing remote electronic monitoring of in vitro diagnostic equipment and laboratory automation systems; platform as a service (PAAS) featuring computer software platform for laboratory and diagnostic equipment information management, monitoring and analysis in the field of in vitro diagnostics; software as a service (SAAS) services featuring software for use in managing data and information in the field of in vitro diagnostics
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Registration Fee Notice Sent
- Registration Pending
- Advertised; Vol.71 Issue 3634
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Examiner's First Report
- Search Recorded
- Pre-Assessment Letter Sent; Goods or Services Not Acceptable
- Formalized
2 earlier steps on the official record.
About SYMPHEOS
Who owns the trademark "SYMPHEOS"?
The CIPO trademark "SYMPHEOS" (application 1958693) is owned by Abbott Laboratories.
What is the status of "SYMPHEOS"?
Its status at the CIPO is: registered.
When was "SYMPHEOS" registered?
It was registered on September 18, 2024 and is due to expire on September 18, 2034.
Get this data via the API
Everything on this page comes from the Signa API. Pull SYMPHEOS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb20-1ad5-73cf-a393-f78269d1dfba
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb20-1ad5-73cf-a393-f78269d1dfba",
"object": "trademark",
"mark_text": "SYMPHEOS",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "1958693",
"filing_date": "2019-04-23",
"nice_classes": [
1,
5,
9,
10,
41,
42
],
"owners": [
{
"name": "Abbott Laboratories",
"entity_id": "ent_019f2852-fb9e-768b-b9d9-62aed3989b7c"
}
]
}